Medulloblastoma: Metabolic Fingerprinting on Synthetic Alloys for Medulloblastoma Diagnosis and Radiotherapy Evaluation (Adv. Mater. 23/2020)

Abstract

In article number 2000906, Mawei Jiang, Kun Qian, and co-workers report synthetic Pd–Au alloys for mass-spectrometry-based metabolic fingerprinting and analysis, toward diagnosis and radiotherapy evaluation of medulloblastoma. Medulloblastoma patients are diagnosed by machine learning, while radiotherapy is monitored and a preliminary panel of serum metabolite biomarkers is identified with gradual changes.